Mu, C.1.2 variants of SARS-CoV2 not found in India so far: INSAOCG

By: |
September 15, 2021 3:15 PM

The consortium has called for more strongly implementing existing recommendations on sequencing of positive samples from international travellers.

No patients from the 18 and under group died, while three died from the over 40 age group and two died from the 19-40 age group.No patients from the 18 and under group died, while three died from the over 40 age group and two died from the 19-40 age group.

India has so far not seen Mu and C.1.2, the two new variants of SARS-CoV2, and the Delta variant and its sub-lineages continue to the main Variants of Concern in the country, INSACOG, the genome sequencing consortium, has said. The consortium has called for more strongly implementing existing recommendations on sequencing of positive samples from international travellers.

The World Health Organisation (WHO) has added B.1.621 (including B.1.621.1) to the list of Variants of Interest (VOI) on August 30 and christened it ”Mu”. It has also added C.1.2 as a new VOI. C.1.2 is a sub-lineage of the C.1 variant described in South Africa but did not spread globally, the INSACOG said.

”Neither Mu, nor C.1.2 are seen in India so far. Existing recommendations on sequencing of positive samples from international travellers may be more strongly implemented. Monitoring and evaluation of further data appears to be adequate at this time,” the INSACOG said in its bulletin dated September 10.

”Delta and Delta sub-lineages continue to be the main VOC in India,” it added. The Delta variant has been driving infections in several countries. In India, it led to a deadly second wave.

The INSACOG said Mu has mutations that indicate potential immune escape properties. There appears to be a reduction in neutralisation capacity of convalescent and vaccine sera, similar to that seen for the Beta variant, but this needs to be confirmed by further studies.

Although the global prevalence of the Mu variant has declined and is currently below 0.1 per cent, the prevalence in Colombia (39 per cent) and Ecuador (13 per cent) has consistently increased, according to the WHO bulletin.

It said the C.1.2 variant seems to have undergone many mutations in a short time, and contains mutations of all the three types that have previously been found to be important for transmissibility and immune escape. The only clinical data for actual transmissibility is a rise from 0.2 per cent in May to two per cent in July, the INSACOG said.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Coronavirus (Covid-19) India Live News: India reports 26,041 new Covid cases today
2Over 2.09 lakh people given COVID-19 vaccine in Delhi
3AstraZeneca Pharma India gets DCGI nod to import, market Selumetinib capsules